Session

Liver & biliary (Posters)

DIP THE TAP - IMPROVING NEEDLE TO DIAGNOSIS TIME IN SPONTANEOUS BACTERIAL PERIOTINITIS: A RENEWED SCREENING ROLE FOR BEDSIDE LEUCOCYTE ESTERASE TEST KITS - DURING COVID 19 PANDEMIC A MULTISITE STUDY
DIP THE TAP - IMPROVING NEEDLE TO DIAGNOSIS TIME IN SPONTANEOUS BACTERIAL PERIOTINITIS: A RENEWED SCREENING ROLE FOR BEDSIDE LEUCOCYTE ESTERASE TEST KITS - DURING COVID 19 PANDEMIC A MULTISITE STUDY

PROCALCITONIN AS A PROGNOSTIC TOOL IN THE MANAGEMENT OF REFRACTORY ASCITES
PROCALCITONIN AS A PROGNOSTIC TOOL IN THE MANAGEMENT OF REFRACTORY ASCITES

THE SYNERGISTIC EFFECTS OF IFN-GAMMA AND IL-1BETA ON THE MECHANISM OF PROGRAMMED CELL DEATH 1 LIGAND 1 EXPRESSION IN HEPATOCELLULAR CARCINOMA
THE SYNERGISTIC EFFECTS OF IFN-GAMMA AND IL-1BETA ON THE MECHANISM OF PROGRAMMED CELL DEATH 1 LIGAND 1 EXPRESSION IN HEPATOCELLULAR CARCINOMA

HEPATOCELLULAR CARCINOMA (HCC) AWARENESS AND SURVEILLANCE IN PATIENTS WITH CHRONIC LIVER DISEASES (CLD) FOLLOWED IN TERTIARY GREEK LIVER CENTERS
HEPATOCELLULAR CARCINOMA (HCC) AWARENESS AND SURVEILLANCE IN PATIENTS WITH CHRONIC LIVER DISEASES (CLD) FOLLOWED IN TERTIARY GREEK LIVER CENTERS

LIVER TRANSAMINASES, LEPTIN AND INTERLEUKIN-6 LEVEL IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS COMBINED WITH OBESITY AND ARTERIAL HYPERTENSION DURING TREATMENT WITH URSODEOXYCHOLIC ACID, STATINS AND SARTANS
LIVER TRANSAMINASES, LEPTIN AND INTERLEUKIN-6 LEVEL IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS COMBINED WITH OBESITY AND ARTERIAL HYPERTENSION DURING TREATMENT WITH URSODEOXYCHOLIC ACID, STATINS AND SARTANS

MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING FOR THE DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS
MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING FOR THE DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS

QUALITY OF LIFE IMPROVEMENT IS A TOP-RATED BUT RARELY ASSESSED OUTCOME IN EUROPEAN AND AUSTRALIAN PATIENTS WITH HEPATIC ENCEPHALOPATHY: QUALITY OF LIFE TARGETING AND MONITORING NEEDS TO BE PRIORITISED
QUALITY OF LIFE IMPROVEMENT IS A TOP-RATED BUT RARELY ASSESSED OUTCOME IN EUROPEAN AND AUSTRALIAN PATIENTS WITH HEPATIC ENCEPHALOPATHY: QUALITY OF LIFE TARGETING AND MONITORING NEEDS TO BE PRIORITISED

PREVALANCE AND SIGNIFICANCE OF ASYMPTOMATIC CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS INFECTIONS IN PATIENTS WITH ALCOHOLIC LIVER DISEASE - TO TREAT OR IGNORE?
PREVALANCE AND SIGNIFICANCE OF ASYMPTOMATIC CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS INFECTIONS IN PATIENTS WITH ALCOHOLIC LIVER DISEASE - TO TREAT OR IGNORE?

ASSOCIATION OF OXIDATIVE STRESS WITH THE SEVERITY OF LIVER FIBROSIS IN PATIENTS WITH OPISTHORCHIS FELINEUS INVASION
ASSOCIATION OF OXIDATIVE STRESS WITH THE SEVERITY OF LIVER FIBROSIS IN PATIENTS WITH OPISTHORCHIS FELINEUS INVASION

THE SUBPOPULATION COMPOSITION OF BLOOD T-KILLERS AND THE FREQUENCY OF SEVERE LIVER FIBROSIS DIFFER IN PATIENTS WITH VIRAL HEPATITIS C WITH GENOTYPES 1 AND 3 IN THE INDUSTRIAL CENTER OF EASTERN SIBERIA
THE SUBPOPULATION COMPOSITION OF BLOOD T-KILLERS AND THE FREQUENCY OF SEVERE LIVER FIBROSIS DIFFER IN PATIENTS WITH VIRAL HEPATITIS C WITH GENOTYPES 1 AND 3 IN THE INDUSTRIAL CENTER OF EASTERN SIBERIA

MACHINE LEARNING MODELS IN THE PREDICTION OF ONE-YEAR MORTALITY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CANCER TREATED WITH IMMUNOTHERAPY
MACHINE LEARNING MODELS IN THE PREDICTION OF ONE-YEAR MORTALITY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CANCER TREATED WITH IMMUNOTHERAPY

A NOMOGRAM-BASED PROGNOSTIC MODEL FOR ADVANCED HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH SORAFENIB: A MULTICENTER STUDY
A NOMOGRAM-BASED PROGNOSTIC MODEL FOR ADVANCED HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH SORAFENIB: A MULTICENTER STUDY

EXPLORE PART B: A PROSPECTIVE, INTERNATIONAL, LONG-TERM NATURAL HISTORY STUDY OF PATIENTS WITH ACUTE HEPATIC PORPHYRIA WITH RECURRENT SYMPTOMS
EXPLORE PART B: A PROSPECTIVE, INTERNATIONAL, LONG-TERM NATURAL HISTORY STUDY OF PATIENTS WITH ACUTE HEPATIC PORPHYRIA WITH RECURRENT SYMPTOMS

INCIDENCE OF CHRONIC KIDNEY DISEASE IN NORTHERN IRELAND LIVER TRANSPLANT RECIPIENTS- A 10 YEAR RETROSPECTIVE REVIEW
INCIDENCE OF CHRONIC KIDNEY DISEASE IN NORTHERN IRELAND LIVER TRANSPLANT RECIPIENTS- A 10 YEAR RETROSPECTIVE REVIEW

COST-EFFECTIVENESS OF RIFAXIMIN-ALPHA VERSUS LACTULOSE IN PREVENTING RECURRENT EPISODES OF OVERT HEPATIC ENCEPHALOPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS
COST-EFFECTIVENESS OF RIFAXIMIN-ALPHA VERSUS LACTULOSE IN PREVENTING RECURRENT EPISODES OF OVERT HEPATIC ENCEPHALOPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS

KALLISTATIN AS A BIOMARKER OF NON-ALCOHOLIC FATTY LIVER DISEASE PROGRESSION IN PATIENTS WITH HYPERTENSION
KALLISTATIN AS A BIOMARKER OF NON-ALCOHOLIC FATTY LIVER DISEASE PROGRESSION IN PATIENTS WITH HYPERTENSION

THE EFFECT OF DIRECT-ACTING ANTIVIRAL REGIMENS AND TELEMEDICINE ON THE TREATMENT OF INMATES WITH CHRONIC HEPATITIS C INFECTION IN ISRAELI PRISONS
THE EFFECT OF DIRECT-ACTING ANTIVIRAL REGIMENS AND TELEMEDICINE ON THE TREATMENT OF INMATES WITH CHRONIC HEPATITIS C INFECTION IN ISRAELI PRISONS

CHARACTERISTICS AND IMPACT OF SEX IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER RETROSPECTIVE STUDY
CHARACTERISTICS AND IMPACT OF SEX IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER RETROSPECTIVE STUDY

RELATIONSHIP BETWEEN INTESTINAL DYSBIOSIS AND OBESITY IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE.
RELATIONSHIP BETWEEN INTESTINAL DYSBIOSIS AND OBESITY IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE.

SIGNIFICANT HARM REDUCTION DESPITE HIGH REINFECTION RATES AMONG ACTIVE PEOPLE WHO INJECT DRUGS ENROLLING IN AN EXTERNALIZED MODEL FOR HCV MICROELIMINATION
SIGNIFICANT HARM REDUCTION DESPITE HIGH REINFECTION RATES AMONG ACTIVE PEOPLE WHO INJECT DRUGS ENROLLING IN AN EXTERNALIZED MODEL FOR HCV MICROELIMINATION

Item 101 - 120 / 270
1 2 3 4 5
6
7 8 9 10 11 12 13 14